Redefining monosomy 5 by molecular cytogenetics in 23 patients with MDS/AML

European Journal of Haematology

Volumn 78, Issue 6, 2007, Pages 457-467

  Herry, Angèle ^a   Douet Guilbert, Nathalie ^a,b   Morel, Frédéric ^a,b   Bris, Marie Josée Le ^b   Braekeleer, Marc De ^a,b  

^a FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

^b CHU MORVAN   (France)

Author keywords

Acute myeloid leukemia; Molecular cytogenetics; Monosomy 5; Myelodysplastic syndrome

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CHROMOSOME 5Q; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION 5; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MONOSOMY; MONOSOMY 5; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; CHROMOSOMES, HUMAN, PAIR 5; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; MONOSOMY; MYELODYSPLASTIC SYNDROMES;

EID: 34248571914     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2007.00847.x     Document Type: Article

References (65)

1. Van den Berghe H, Cassiman JJ, David G, Fryns JP, Michaux JL, Sokal G. Distinct haematological disorder with deletion of long arm of the no. 5 chromosome. Nature 1974 251 : 437 8.
2. Van den Berghe H, Vermaelen K, Mecucci C, Barbieri D, Tricot G. The 5q- anomaly. Cancer Genet Cytogenet 1985 17 : 189 255.
3. Boultwood J, Lewis S, Wainscoat JS. The 5q- syndrome. Blood 1994 84 : 3253 60.
4. Rowley JD, Golomb HM, Vardiman JW. Nonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease. Blood 1981 58 : 759 67.
5. Mitelman F, Nilsson PG, Brandt L, Alimena G, Gastaldi R, Dallapiccola B. Chromosome pattern, occupation, and clinical features in patients with acute nonlymphocytic leukemia. Cancer Genet Cytogenet 1981 4 : 197 214.
6. LeBeau MM, Albain KS, Larson RA, Vardiman JW, Davis EM, Blough RR, Golomb HM, Rowley JD. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol 1986 4 : 325 45.
7. Nimer SD, Golde DW. The 5q- abnormality. Blood 1987 70 : 1705 12.
8. LeBeau MM. Deletions of chromosome 5 in malignant myeloid disorders. Cancer Surv 1992 15 : 143 59.
9. Michalova K, Musilova J, Zemanova Z. Cytogenetic abnormalities in 532 patients with myeloid leukemias and myelodysplastic syndrome. The Czechoslovak MDS Cooperative Group. Czech Med 1990 13 : 133 44.
10. Haase D, Fonatsch C, Freund M, Wormann B, Bodenstein H, Bartels H, Stollmann-Gibbels B, Lengfelder E. Cytogenetic findings in 179 patients with myelodysplastic syndromes. Ann Hematol 1995 70 : 171 87.
11. Fenaux P, Morel P, Lai JL. Cytogenetics of myelodysplastic syndromes. Semin Hematol 1996 33 : 127 38.
12. Van den Berghe H, Michaux L. 5q-, twenty-five years later: a synopsis. Cancer Genet Cytogenet 1997 94 : 1 7.
13. Olney HJ, Le Beau MM. The cytogenetics of myelodysplastic syndromes. Best Pract Res Clin Haematol 2001 14 : 479 95.
14. Smith SM, Le Beau MM, Huo D, Karrison T, Sobecks RM, Anastasi J, Vardiman JW, Rowley JD, Larson RA. Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. Blood 2003 102 : 43 52.
15. Gozzetti A, Le Beau MM. Fluorescence in situ hybridization: uses and limitations. Semin Hematol 2000 37 : 320 33.
16. Callen DF, Eyre HJ, Ringenbergs ML, Freemantle CJ, Woodroffe P, Haan EA. Chromosomal origin of small ring marker chromosomes in man: characterization by molecular genetics. Am J Hum Genet 1991 48 : 769 82.
17. Daniel A, Malafiej P, Preece K, Chia N, Nelson J, Smith M. Identification of marker chromosomes in thirteen patients using FISH probing. Am J Med Genet 1994 53 : 8 18.
18. Herry A, Luquet I, Leglise MC, Le Calvez G, Abgrall JF, Lessard M. Efficiency of fluorescence in situ hybridization (FISH) in cytogenetic study of hematological disorders. Blood 1996 80 : A3352.
19. Speicher MR, Ballard GS, Ward DC. Karyotyping human chromosomes by combinatorial multi-fluor FISH. Nat Genet 1996 12 : 368 75.
20. Schrock E, du Manoir S, Veldman T, et al. Multicolor spectral karyotyping of human chromosomes. Science 1996 273 : 494 7.
21. Lessard M, Herry A, Berthou C, et al. Chromosome 8 tetrasomies and pentasomies - a clonal abnormality closely associated with acute monocytic leukaemia. Leuk Lymphoma 1997 27 : 127 35.
22. Veldman T, Vignon C, Schrock E, Rowley JD, Ried T. Hidden chromosome abnormalities in haematological malignancies detected by multicolour spectral karyotyping. Nat Genet 1997 15 : 406 10.
23. Fleischman EW, Reshmi S, Sokova OI, Kirichenko OP, Konstantinova LN, Kulagina OE, Frenkel MA, Rowley JD. Increased karyotype precision using fluorescence in situ hybridization and spectral karyotyping in patients with myeloid malignancies. Cancer Genet Cytogenet 1999 108 : 166 70.
24. Brezinova J, Zemanova Z, Cermak J, Michalova K. Fluorescence in situ hybridization confirmation of 5q deletions in patients with hematological malignancies. Cancer Genet Cytogenet 2000 117 : 45 9.
25. Pedersen-Bjergaard J, Timshel S, Klarskov Andersen M, Thoger Anderson AS, Philip P. Cytogenetically unrelated clones in therapy-related myelodysplasia and acute myeloid leukemia: experience from the Copenhagen series updated to 180 consecutive cases. Genes Chromosomes Cancer 1998 23 : 337 49.
26. Lindvall C, Nordenskjold M, Porwit A, Bjorkholm M, Blennow E. Molecular cytogenetic characterization of acute myeloid leukemia and myelodysplastic syndromes with multiple chromosome rearrangements. Haematologica 2001 86 : 1158 64.
27. Mufti GJ. Pathobiology, classification, and diagnosis of myelodysplastic syndrome. Best Pract Res Clin Haematol 2004 17 : 543 57.
28. Barouk-Simonet E, Soenen-Cornu V, Roumier C, Cosson A, Lai JL, Fenaux P, Preudhomme C. Role of multiplex FISH in identifying chromosome involvement in myelodysplastic syndromes and acute myeloid leukemias with complex karyotypes: a report on 28 cases. Cancer Genet Cytogenet 2005 157 : 118 26.
29. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982 51 : 189 99.
30. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 1985 103 : 620 5.
31. Brunning RD, Bennett JM, Flandrin G, et al. Myelodysplastic syndromes, acute myeloid leukaemias. In : Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours. Lyon : IARC Press, 2001 : 61 107.
32. ISCN. An International System for Human Cytogenetic Nomenclature. Basel : S. Karger, 1995.
33. Senger G, Chudoba I, Plesch A. Multicolor-FISH - the identification of chromosome aberrations by 24 colors. BIOforum 1998 9 : 499 503.
34. Wang MR, Perissel B, Malet P. Rehybridization on metaphases studied previously by FISH. Cancer Genet Cytogenet 1995 85 : 58 60.
35. Shen Y, Xue Y, Li J. Detection of -5/5q- chromosome abnormality in myelodysplastic syndromes by interphase fluorescence in situ hybridization. Zhonghua Xue Ye Xue Za Zhi 2001 22 : 517 9.
36. Romeo M, Chauffaille M, Silva M, Bahia D, Kerbauy J. Comparison of cytogenetics with FISH in 40 myelodysplastic syndrome patients. Leuk Res 2002 26 : 993.
37. Beyer V, Castagne C, Muhlenmatter D, et al. Systematic screening at diagnosis of -5/del(5)(q31), -7, or chromosome 8 aneuploidy by interphase fluorescence in situ hybridization in 110 acute myelocytic leukemia and high-risk myelodysplastic syndrome patients: concordances and discrepancies with conventional cytogenetics. Cancer Genet Cytogenet 2004 152 : 29 41.
38. Ogasawara T, Yasuyama M, Kawauchi K. Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2). Am J Hematol 2005 79 : 136 41.
39. Schoch C, Bursch S, Kern W, Schnittger S, Hiddemann W, Haferlach T. Gain of an isochromosome 5p: a new recurrent chromosome abnormality in acute monoblastic leukemia. Cancer Genet Cytogenet 2001 127 : 85 8.
40. Herry A, Morel F, Le Bris MJ, et al. Molecular cytogenetic characterization of chromosome 5 abnormalities in a series of 55 patients with myelodysplastic syndromes. Leuk Res 2003 27 : S23 4.
41. Anderson K, Arvidsson I, Jacobsson B, Hast R. Fluorescence in situ hybridization for the study of cell lineage involvement in myelodysplastic syndromes with chromosome 5 anomalies. Cancer Genet Cytogenet 2002 136 : 101 7.
42. Bram S, Swolin B, Rodjer S, Stockelberg D, Ogard I, Back H. Is monosomy 5 an uncommon aberration? Fluorescence in situ hybridization reveals translocations and deletions in myelodysplastic syndromes or acute myelocytic leukemia. Cancer Genet Cytogenet 2003 142 : 107 14.
43. Bram S, Rodjer S, Swolin B. Several chromosomes involved in translocations with chromosome 5 shown with fluorescence in situ hybridization in patients with malignant myeloid disorders. Cancer Genet Cytogenet 2004 155 : 74 8.
44. Westbrook CA, Keinanen MJ. Myeloid malignancies and chromosome 5 deletions. Clin Haematol 1992 5 : 931 42.
45. de Greef GE, Hagemeijer A. Molecular and cytogenetic abnormalities in acute myeloid leukaemia and myelodysplastic syndromes. Clin Haematol 1996 9 : 1 18.
46. Gibbons B, Lillington DM, Monard S, Young BD, Cheung KI, Lister TA, Kearney L. Fluorescence in situ hybridisation studies to characterise complete and partial monosomy 7 in myeloid disorders. Genes Chromosomes Cancer 1994 10 : 244 9.
47. Viguie F, Prigent Y, Ramond S, Baumelou E, Cadiou M, Dreyfus F, Zittoun R. Fluorescence in situ hybridization analysis of minute marker chromosomes in leukemia with monosomy 7. Leukemia 1995 9 : 1154 8.
48. Tosi S, Harbott J, Haas OA, Douglas A, Hughes DM, Ross FM, Biondi A, Scherer SW, Kearney L. Classifications of deletions and identification of cryptic translocations involving 7q by fluorescence in situ hybridization (FISH). Leukemia 1996 10 : 644 9.
49. Lessard M, Herry A, Berthou C, Léglise MC, Abgrall JF, Morice P, Flandrin G. FISH investigation of 5q and 7q deletions in MDS/AML reveals hidden translocations, insertions and fragmentations of the same chromosomes. Leuk Res 1998 212 : 303 12.
50. La Starza R, Stella M, Testoni N, Di Bona E, Ciolli S, Marynen P, Martelli MF, Mandelli F, Mecucci C. Characterization of 12p molecular events outside ETV6 in complex karyotypes of acute myeloid malignancies. Br J Haematol 1999 107 : 340 6.
51. Cremer T, Popp S, Emmerich P, Lichter P, Cremer C. Rapid metaphase and interphase detection of radiation-induced chomosome aberrations in human lymphocytes by chromosomal suppression in situ hybridization. Cytometry 1990 11 : 110 8.
52. Andersen MK, Pedersen-Bjergaard J. Increased frequency of dicentric chromosomes in therapy-related MDS and AML compared to de novo disease is significantly related to previous treatment with alkylating agents and suggests a specific susceptibility to chromosome breakage at the centromere. Leukemia 2000 14 : 105 11.
53. Heller A, Rubtsov N, Kytola S, Karamysheva TV, Sablina OV, Degtvareva MM, Starke H, Metzke H, Claussen U, Liehr T. Highly complex karyotypic changes in acute myelogenous leukemia: a case report. Int J Oncol 2003 23 : 139 43.
54. Heller A, Trifonov V, Rubtsov N, Sauerbrey A, Starke H, Loncarevic IF, Claussen U, Liehr T. Complex chromosomal rearrangements in a secondary acute myeloblastic leukemia after chemotherapy in TRAPS. Oncol Rep 2003 10 : 1789 92.
55. Andersen MK, Christiansen DH, Pedersen-Bjergaard J. Centromeric breakage and highly rearranged chromosome derivatives associated with mutations of TP53 are common in therapy-related MDS and AML after therapy with alkylating agents: an M-FISH study. Genes Chromosomes Cancer 2005 42 : 358 71.
56. Schoch C, Haferlach T, Bursch S, Gerstner D, Schnittger S, Dugas M, Kern W, Loffler H, Hiddemann W. Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrat karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH. Genes Chromosomes Cancer 2002 35 : 29.
57. Van Limbergen H, Poppe B, Michaux L, Herens C, Brown J, Noens L, Berneman Z, De Bock R, de Paepe A, Speleman F. Identification of cytogenetic subclasses and recurring chromosomal aberrations in AML and MDS with complex karyotypes using M-FISH. Genes Chromosomes Cancer 2002 33 : 60 72.
58. Martinez-Ramirez A, Urioste M, Alvarez S, Vizmanos JL, Calasanz MJ, Cigudosa JC, Benitez J. Cytogenetic profile of myelodysplastic syndromes with complex karyotypes: an analysis using spectral karyotyping. Cancer Genet Cytogenet 2004 153 : 39 47.
59. Alvarez S, Cigudosa JC. Gains, losses and complex karyotypes in myeloid disorders: a light at the end of the tunnel. Hematol Oncol 2005 23 : 18 25.
60. Schoch C, Kohlmann A, Dugas M, Kern W, Hiddemann W, Schnittger S, Haferlach T. Genomic gains and losses influence expression levels of genes located within the affected regions: a study on acute myeloid leukemias with trisomy 8, 11, or 13, monosomy 7, or deletion 5q. Leukemia 2005 19 : 1224 8.
61. Schoch C, Kern W, Kohlmann A, Hiddemann W, Schnittger S, Haferlach T. Acute myeloid leukemia wiht a complex aberrant karyotype is a distinct biological entity characterized by genomic imbalances and a specific gene expression profile. Genes Chromosomes Cancer 2005 43 : 227 38.
62. Sabatier L, Ricoul M, Pottier G, Murnane JP. The loss of a single telomere can result in instability of multiple chromosomes in a human tumor cell line. Mol Cancer Res 2005 3 : 139 50.
63. De Lange T. Telomere dynamics and genome instability in human cancer. In : Blackburn EH, Greider CW, eds. Telomeres. Plainview, NY : Cold Spring Harbor Press, 1995 : 265 93.
64. Murnane JP, Sabatier L. Chromosome rearrangements resulting from telomere dysfunction and their role in cancer. Bioessays 2004 26 : 1164 74.
65. Martinez-Ramirez A, Urioste M, Melchor L, Blesa D, Valle L, Alvarez de Andres S, Kok K, Calasanz MJ, Cigudosa JC, Benitez J. Analysis of myelodysplastic syndromes with complex karyotypes by high-resolution comparative genomic hybridization and subtelomeric CGH array. Genes Chromosomes Cancer 2005 42 : 287 98.